ZD6474, a novel antiangiogenic agent, in combination with docetaxel in patients with NSCLC: Results of the run-in phase of a two-part, randomized phase II study - Concepedia

Concepedia

Publication | Closed Access

ZD6474, a novel antiangiogenic agent, in combination with docetaxel in patients with NSCLC: Results of the run-in phase of a two-part, randomized phase II study

20

Citations

0

References

2004

Year

John V. Heymach, Runyu Dong, Isaiah W. Dimery, C Wheeler, P. Fidias, C. Lu, Bruce E. Johnson, Roy S. Herbst

Journal of Clinical Oncology

Abstract

3051